Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173882 | SCV000225050 | pathogenic | not provided | 2013-09-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000803322 | SCV000943186 | pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2023-09-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp358Cysfs*13) in the MCCC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MCCC1 are known to be pathogenic (PMID: 11181649, 15359379, 22642865). This variant is present in population databases (rs398124350, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with MCCC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 95938). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000803322 | SCV004194266 | pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2024-03-30 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000803322 | SCV004238278 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2023-02-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000803322 | SCV005661959 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2024-03-06 | criteria provided, single submitter | clinical testing |